Work

Survival of patients (pts) with metastatic melanoma treated with the anti-CTLA4 monoclonal antibody (mAb) CP-675,206 in a phase I/II study

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.8524

Authors: J. Gomez-Navarro, S. Antonia, J. Sosman, J. M. Kirkwood, B. Redman, T. F. Gajewski, D. Pavlov, C. Bulanhagui, A. Ribas, L. H. Camacho

Institutions: University of California, Los Angeles, University of Pittsburgh, Moffitt Cancer Center, University of Chicago, U-M Rogel Cancer Center, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W180009382

Cites:

Cited by: 19

Related to: 10